All natural healing is guaranteed with patience and understanding. Having a better understanding of your condition can pave the path to lifelong success in controlling it for good. Knowledge of your disorder, and all the contributing factors in your life having led up to your very current ailment(s), can make for a better understanding of the necessary approach and commitment to resolving it.
Inflammatory diseases are not an overnight occurrence. Some of you may be approaching natural healing as your first form of treatment, while many of you have suffered for years upon years, and the prescription drugs are no longer helping you. Natural healing may not be a “quick-fix”, but it also avoids the common “band-aid” for your symptoms like many modern-day prescription drugs. Instead of treating your symptoms, natural healing aims to repair the problem that is causing your symptoms in the first place.
Do you feel like you’ve already tried everything to heal on your own, without long-term success?
Continue reading “Can you repair Gout and Arthritis on your own?”
Things we hear often:
According to the latest CARES trial, the Gout drug Febuxostat (Uloric) failed up against Allopurinol when it came down to a combined rate of fatal and nonfatal adverse events for those that suffer with both Gout and Cardiovascular disease. In fact, there was a significant increased risk of death for those that took this drug for Gout while also suffering from heart disease.
The trial was mandated by the FDA and consisted of 6,190 patients, 84% of which were men. Cardiovascular risk is naturally increased in patients with Gout. The study was attempting to look at any difference in outcome for these patients taking Febuxostat, a nonpurine xanthine oxidase inhibitor, or those taking Allopurinol, a purine base analogue xanthine oxidase inhibitor. The patients were followed for a median of 32 months, and a maximum of 85 months. Without diving into all of the ratio statistics, the all-cause and cardiovascular mortality rate was higher in the Febuxostat group, 34% and 22% higher respectively. Continue reading “New evidence of increased risk of death with Febuxostat (Uloric)”